|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Viridian Therapeutics (NASDAQ: VRDN) through any online brokerage.
The latest price target for Viridian Therapeutics (NASDAQ: VRDN) was reported by Evercore ISI Group on October 12, 2021. The analyst firm set a price target for 40.00 expecting VRDN to rise to within 12 months (a possible 128.18% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Viridian Therapeutics (NASDAQ: VRDN) is $17.53 last updated Mon Oct 25 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Viridian Therapeutics.
Viridian Therapeutics’s $Q3 earnings are confirmed for after-market on $November 9, 2021.
There is no upcoming split for Viridian Therapeutics.
Viridian Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.